Lippman Evan insider trades
Lippman Evan has filed 4 Form 4s with the SEC that we hold, all for Teva Pharmaceutical Industries LTD (TEVA), as EVP, Business Development. Across all of them we count 0 purchases worth $0 and 3 sales worth $2.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($2.2M). The largest single trade was a sale of 35,912 shares of Teva Pharmaceutical Industries LTD worth $1.3M, dated 2026-05-14. The first filing on our record is dated 2025-05-19 and the latest 2026-08-19.
Teva Pharmaceutical Industries LTD (TEVA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-05-14 | S, sale reported on Form 4 | 5,746 | $204.4K | 2026-05-18 |
| 2026-05-14 | S, sale reported on Form 4 | 35,912 | $1.3M | 2026-05-18 |
| 2026-08-17 | S, sale reported on Form 4 | 18,600 | $680.3K | 2026-08-19 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2062834) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms